EMAIL THIS PAGE TO A FRIEND

Oncology reports

Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.


PMID 25333671

Abstract

Non-small cell lung cancer (NSCLC) accounts for approximately 80-85% of all lung cancer cases. Cigarette smoking is the number one risk factor which is attributed to more than four out of five cases of lung cancers. The prognostic impact of cell cycle regulation-associated tumor suppressors including p53 and p21 for NSCLC is still controversial. In the present study, we examined p53 and p21 expression using immunoblotting in tumor and adjacent non-cancerous tissues from NSCLC patients. Moreover, tissue microarrays (TMAs) including 150 specimens was used to examine p53 and p21 expression by immunohistochemical staining (IHC). The association between p53/p21 and various clinicopathological characteristics was evaluated. Kaplan-Meier overall survival was used to analyze the association between p53/p21 expression and prognosis of NSCLC patients, as well as the association of cigarette smoking with p53/p21 expression and prognosis. The results of the immunoblotting showed that expression of p53 and p21 in tumor tissues was significantly higher than that in the matched adjacent non-cancerous tissues (P<0.001 and P<0.05, respectively). The IHC results showed that 50.67% of the cases had high expression of p21; however, the percentage of patients having high expression of p53 was 31.3%. Univariate and Cox regression models were used to evaluate the factors related to prognosis with p53 and p21 expression. Multivariate analysis indicated that p53 expression was an independent prognostic factor for NSCLC (P=0.005), while p21 could not serve as an independent prognostic factor (P=0.123). In addition, smoking history was closely related to lung cancer risk (P=0.041), but could not be an independent assessment factor (P=0.740). In this study, we further demonstrated the association of p53/p21 expression and cigarette smoking. Our results suggest that cigarette smoking and overexpression of p53 or p21 are associated with poor prognosis. The combination of p53/p21 expression and smoking history may be a useful biomarker for tumor progression and prognosis of NSCLC patients.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1306667
ANTI-P53 (S15) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1306713
ANTI-P53 (S315) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1306623
ANTI-P53 (SUMOYLATION SITE SPECIFIC) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
P4235 Anti-p53 antibody produced in sheep, fractionated antiserum, buffered aqueous solution
SAB4300365
Anti-TP53 (Ab-18) antibody produced in rabbit, affinity isolated antibody
SAB4300369
Anti-TP53 (Ab-315) antibody produced in rabbit, affinity isolated antibody
SAB4300366
Anti-TP53 (Ab-33) antibody produced in rabbit, affinity isolated antibody
SAB4300367
Anti-TP53 (Ab-37) antibody produced in rabbit, affinity isolated antibody
SAB4300368
Anti-TP53 (Ab-46) antibody produced in rabbit, affinity isolated antibody
SAB4300362
Anti-TP53 (Ab-6) antibody produced in rabbit, affinity isolated antibody
SAB4300363
Anti-TP53 (Ab-9) antibody produced in rabbit, affinity isolated antibody
SAB2102511
Anti-TP53 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2102512
Anti-TP53 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB2102513
Anti-TP53 (ab3) antibody produced in rabbit, affinity isolated antibody
SAB2102514
Anti-TP53 (ab4) antibody produced in rabbit, affinity isolated antibody
SAB2102515
Anti-TP53 (ab5) antibody produced in rabbit, affinity isolated antibody
SAB1406544
Anti-TP53 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV02055
Anti-TP53 antibody produced in rabbit, IgG fraction of antiserum
AV37163
Anti-TRP53 antibody produced in rabbit, IgG fraction of antiserum
SAB2106418
Anti-TRP53 antibody produced in rabbit, affinity isolated antibody
P6749
Monoclonal Anti-p53 antibody produced in mouse, clone PAb1801, purified from hybridoma cell culture
AMAB90956
Monoclonal Anti-p53 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL2199, purified immunoglobulin, buffered aqueous glycerol solution
P5813
Monoclonal Anti-p53 antibody produced in mouse, clone BP53-12, ascites fluid
P8999
Monoclonal Anti-p53 antibody produced in mouse, clone DO-7, purified from hybridoma cell culture
P7874 Monoclonal Anti-p53 antibody produced in mouse, ~2 mg/mL, clone DO-2, purified immunoglobulin, buffered aqueous solution
P6874
Monoclonal Anti-p53 antibody produced in mouse, clone DO-1, purified from hybridoma cell culture
WH0007157M1
Monoclonal Anti-TP53 antibody produced in mouse, clone 2C3, purified immunoglobulin, buffered aqueous solution
SAB1404483
Monoclonal Anti-TP53 antibody produced in mouse, clone 2C11, purified immunoglobulin, buffered aqueous solution
PLA0072
Rabbit anti-p53 Antibody, Affinity Purified